MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueno, S.
Right arrow Articles by Steinbach, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueno, S.
Right arrow Articles by Steinbach, J. H.

Endogenous subunits can cause ambiguities in the pharmacology of exogenous gamma-aminobutyric acidA receptors expressed in human embryonic kidney 293 cells

S Ueno, C Zorumski, J Bracamontes and JH Steinbach

Departments of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

The physiological and pharmacological properties of GABAA receptors have been studied extensively after the expression of subunits in non- neural cells. Many of these studies have used the human embryonic kidney cell line HEK 293. We examined the properties of subunits that result in the expression of low levels of functional receptors and found that the properties of the gamma-aminobutyric acid (GABA)- elicited responses in transfected HEK 293 cells differ from expectations based on previous work and are consistent with the idea that the expressed receptors do not necessarily contain the expected subunits. In particular, expression of a mutated beta 2 subunit [beta 2(Y205S)] in combination with alpha 1 and gamma 2L results in cells that have large responses to pentobarbital (as expected) but also show appreciable responses to GABA (contrary to expectation). Furthermore, transfection of HEK 293 cells with alpha 1 plus gamma 2L subunits results in responses to GABA that are potentiated by the drug loreclezole, suggesting that a subunit resembling the beta 2 or beta 3 subunit had assembled with the alpha 1 gamma 2L subunits. In addition, some nontransfected HEK 293 cells respond to applications of GABA, and transfection of cells with alpha 1, beta 1, or gamma 2L subunits alone can result in the expression of GABA-elicited currents. In comparison, when QT6 quail fibroblasts are used as the expression system, no responses were seen in untransfected cells or in cells transfected with alpha 1, beta 1, or gamma 2L subunits alone or alpha 1 gamma 2L subunits. Furthermore, no response to GABA was seen in QT6 cells transfected with alpha 1 beta 2(Y205S) gamma 2L subunits, although cells gave strong responses to pentobarbital. These observations indicate that caution must be taken in interpreting the results of studies of the properties of GABAA receptors expressed in HEK 293 cells if the exogenous subunits result in the expression of low levels of functional GABAA receptors.

Volume 50, Issue 4, pp. 931-938, 10/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. Akk, P. Li, J. Bracamontes, D. E. Reichert, D. F. Covey, and J. H. Steinbach
Mutations of the GABA-A Receptor {alpha}1 Subunit M1 Domain Reveal Unexpected Complexity for Modulation by Neuroactive Steroids
Mol. Pharmacol., September 1, 2008; 74(3): 614 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. Li, H.-J. Shu, C. Wang, S. Mennerick, C. F. Zorumski, D. F. Covey, J. H. Steinbach, and G. Akk
Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA-A receptor potentiation
J. Physiol., November 1, 2007; 584(3): 789 - 800.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Li, J. Bracamontes, B. W. Katona, D. F. Covey, J. H. Steinbach, and G. Akk
Natural and Enantiomeric Etiocholanolone Interact with Distinct Sites on the Rat {alpha}1beta2{gamma}2L GABAA Receptor
Mol. Pharmacol., June 1, 2007; 71(6): 1582 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
A. Rosen, M. Bali, J. Horenstein, and M. H. Akabas
Channel Opening by Anesthetics and GABA Induces Similar Changes in the GABAA Receptor M2 Segment
Biophys. J., May 1, 2007; 92(9): 3130 - 3139.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Yamashita, W. Marszalec, J. Z. Yeh, and T. Narahashi
Effects of Ethanol on Tonic GABA Currents in Cerebellar Granule Cells and Mammalian Cells Recombinantly Expressing GABAA Receptors
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 431 - 438.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
J. Yang, Q. Cheng, A. Takahashi, and F. Goubaeva
Kinetic Properties of GABA {rho}1 Homomeric Receptors Expressed in HEK293 Cells
Biophys. J., September 15, 2006; 91(6): 2155 - 2162.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Mennerick, Y. He, X. Jiang, B. D. Manion, M. Wang, A. Shute, A. Benz, A. S. Evers, D. F. Covey, and C. F. Zorumski
Selective Antagonism of 5{alpha}-Reduced Neurosteroid Effects at GABAA Receptors
Mol. Pharmacol., May 1, 2004; 65(5): 1191 - 1197.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Darbandi-Tonkabon, W. R. Hastings, C.-M. Zeng, G. Akk, B. D. Manion, J. R. Bracamontes, J. H. Steinbach, S. J. Mennerick, D. F. Covey, and A. S. Evers
Photoaffinity Labeling with a Neuroactive Steroid Analogue. 6-AZI-PREGNANOLONE LABELS VOLTAGE-DEPENDENT ANION CHANNEL-1 IN RAT BRAIN
J. Biol. Chem., April 4, 2003; 278(15): 13196 - 13206.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Scheller and S. A. Forman
Coupled and Uncoupled Gating and Desensitization Effects by Pore Domain Mutations in GABAA Receptors
J. Neurosci., October 1, 2002; 22(19): 8411 - 8421.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. D. Krasowski, S. E. Finn, Q. Ye, and N. L. Harrison
Trichloroethanol Modulation of Recombinant GABAA, Glycine and GABA rho 1 Receptors
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 934 - 942.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. D. Krasowski, V. V. Koltchine, C. E. Rick, Q. Ye, S. E. Finn, and N. L. Harrison
Propofol and Other Intravenous Anesthetics Have Sites of Action on the gamma -Aminobutyric Acid Type A Receptor Distinct from That for Isoflurane
Mol. Pharmacol., March 1, 1998; 53(3): 530 - 538.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
G. H. Gorrie, Y. Vallis, A. Stephenson, J. Whitfield, B. Browning, T. G. Smart, and S. J. Moss
Assembly of GABAA Receptors Composed of alpha 1 and beta 2 Subunits in Both Cultured Neurons and Fibroblasts
J. Neurosci., September 1, 1997; 17(17): 6587 - 6596.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q. Wan, H. Y. Man, J. Braunton, W. Wang, M. W. Salter, L. Becker, and Y. T. Wang
Modulation of GABAA Receptor Function by Tyrosine Phosphorylation of beta  Subunits
J. Neurosci., July 1, 1997; 17(13): 5062 - 5069.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Ueno, J. Bracamontes, C. Zorumski, D. S. Weiss, and J. H. Steinbach
Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor
J. Neurosci., January 15, 1997; 17(2): 625 - 634.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics